These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 14967369

  • 1. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study.
    D'Angelo A, Davies R, Salah E, Nix BA, Amso NN.
    Fertil Steril; 2004 Feb; 81(2):332-6. PubMed ID: 14967369
    [Abstract] [Full Text] [Related]

  • 2. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 3. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y, Yu Q, Zhang YW, He FF, Sun ZY.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [Abstract] [Full Text] [Related]

  • 4. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 5. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
    Nardo LG, Cheema P, Gelbaya TA, Horne G, Fitzgerald CT, Pease EH, Brison DR, Lieberman BA.
    Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
    [Abstract] [Full Text] [Related]

  • 6. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study.
    Fábregues F, Peñarrubia J, Vidal E, Casals G, Vanrell JA, Balasch J.
    Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755
    [Abstract] [Full Text] [Related]

  • 7. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ, Li XM, Chen XM, Zhang L.
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep 01; 122(1):79-84. PubMed ID: 16154042
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome.
    Barak V, Elchalal U, Edelstein M, Kalickman I, Lewin A, Abramov Y.
    Fertil Steril; 2004 Aug 01; 82(2):415-20. PubMed ID: 15302292
    [Abstract] [Full Text] [Related]

  • 9. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
    Schmidt DW, Maier DB, Nulsen JC, Benadiva CA.
    Fertil Steril; 2004 Oct 01; 82(4):841-6. PubMed ID: 15482757
    [Abstract] [Full Text] [Related]

  • 10. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, García-Velasco JA, Simón C, Pellicer A.
    Hum Reprod; 2006 Jun 01; 21(6):1453-60. PubMed ID: 16488907
    [Abstract] [Full Text] [Related]

  • 11. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
    Gera PS, Tatpati LL, Allemand MC, Wentworth MA, Coddington CC.
    Fertil Steril; 2010 Jun 01; 94(1):173-8. PubMed ID: 19356753
    [Abstract] [Full Text] [Related]

  • 12. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
    Lee KH, Kim SH, Jee BC, Kim YJ, Suh CS, Kim KC, Lee WD.
    Fertil Steril; 2010 May 01; 93(7):2274-80. PubMed ID: 19249755
    [Abstract] [Full Text] [Related]

  • 13. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati, Shibahara H, Hirano Y, Suzuki T, Takamizawa S, Suzuki M.
    Fertil Steril; 2004 Sep 01; 82(3):579-85. PubMed ID: 15374699
    [Abstract] [Full Text] [Related]

  • 14. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A, Coccia ME, Fedi S, Gori AM, Cellai AP, Scarselli GF, Prisco D, Abbate R.
    Blood Coagul Fibrinolysis; 2003 Apr 01; 14(3):277-82. PubMed ID: 12695751
    [Abstract] [Full Text] [Related]

  • 15. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr 01; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

  • 16. The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation.
    Abdalla H, Nicopoullos JD.
    Fertil Steril; 2010 Oct 01; 94(5):1757-63. PubMed ID: 19939366
    [Abstract] [Full Text] [Related]

  • 17. Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment.
    Mocanu E, Redmond ML, Hennelly B, Collins C, Harrison R.
    Hum Fertil (Camb); 2007 Sep 01; 10(3):175-81. PubMed ID: 17786650
    [Abstract] [Full Text] [Related]

  • 18. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
    Esinler I, Bayar U, Bozdag G, Yarali H.
    Fertil Steril; 2005 Oct 01; 84(4):932-7. PubMed ID: 16213846
    [Abstract] [Full Text] [Related]

  • 19. [Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle].
    Miao MF, Huang HF.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb 01; 41(2):114-7. PubMed ID: 16640861
    [Abstract] [Full Text] [Related]

  • 20. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM.
    Hum Reprod; 2005 Nov 01; 20(11):3167-72. PubMed ID: 16006465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.